Company: IPODW
Filing Date: 2025-03-07
Form Type: S-1
Source: 0001213900-25-021721
Chunk: 15

Company: Dune Acquisition Corp II
Filing Date: 2025-03-07
Form: S-1
Chunk 15
---
 adjustment as provided herein. In the case that additional Class A ordinary shares, or equity -linkedsecurities (as described herein), are issued or deemed issued in excess of the amounts issued in this offering and related to the closing of our initial business combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti -dilutionadjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as -convertedbasis, approximately 28.6% of the sum of all Class A ordinary shares issued and outstanding upon the completion of this offering (including any Class A ordinary shares issued pursuant to the underwriters’ over -allotmentoption and excluding the Class A ordinary shares underlying the private placement warrants issued to the sponsor). The anti -dilutionprovisions in our Class B ordinary shares may result in material dilution to the public shareholders. (2)The non -managingsponsor investors have expressed an interest to purchase, indirectly through the purchase of non -managingsponsor membership interests, an aggregate of 1,000,000 private placement warrants at a price of $1.00 per warrant ($1,000,000 in the aggregate) in a private placement that will close simultaneously with the closing of this offering. (3)Subject to each non -managingsponsor investor purchasing the private placement warrants allocated to it, sponsor will issue membership interests at a nominal purchase price of approximately $0.001 to the non -managingsponsor investors reflecting interests in an aggregate of _____ founder shares held by sponsor. Because our sponsor acquired the founder shares at a nominal price of approximately $0.004 per founder share, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering. See the section titled “Risk Factors — Risks Relating to our Securities — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.” Our proposed initial business combination may impose a minimum cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions. In the event